Development of an I-A(g7)-expressing antigen-presenting cell line: Intrinsic molecular defect in compact I-A(g7) dimer generation

Journal of Autoimmunity

Volumn 11, Issue 1, 1998, Pages 63-72

  Nabavieh, Ali ^c   Chou, Henry ^a   Volokhov, Irina ^a   Lee, James E ^c   Purdy, Lisa E ^b   Elliott, John F ^b   Singh, Bhagirath ^a   Madrenas, Joaquin ^a  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

^c NONE

Author keywords

Antigen presenting cell line; Diabetes; MHC

Indexed keywords

DIMER; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; EPITOPE; GLUTAMATE DECARBOXYLASE; HLA ANTIGEN CLASS 2;

ANIMAL CELL; ANTIGEN PRESENTATION; ARTICLE; AUTOIMMUNITY; FIBROBLAST CULTURE; HAPLOTYPE; HYBRIDOMA; IMMUNOGENETICS; INSULIN DEPENDENT DIABETES MELLITUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE; ANIMAL; ANTIGEN PRESENTING CELL; BAGG ALBINO MOUSE; BIOSYNTHESIS; CELL LINE; CULTURE TECHNIQUE; CYTOLOGY; DIMERIZATION; GENETIC TRANSFECTION; GENETICS; IMMUNOLOGY; IMMUNOPHENOTYPING; L CELL; METABOLISM; METHODOLOGY; NONOBESE DIABETIC MOUSE;

ANIMALS; ANTIGEN PRESENTATION; ANTIGEN-PRESENTING CELLS; CELL CULTURE TECHNIQUES; CELL LINE; DIABETES MELLITUS, TYPE 1; DIMERIZATION; EPITOPES; GLUTAMATE DECARBOXYLASE; HISTOCOMPATIBILITY ANTIGENS CLASS II; HYBRIDOMAS; IMMUNOPHENOTYPING; L CELLS (CELL LINE); MICE; MICE, INBRED BALB C; MICE, INBRED NOD; T-LYMPHOCYTES; TRANSFECTION;

EID: 0031594770     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.1997.0176     Document Type: Article

References (52)

1. Castano L., Eisenbarth G.S. 1990. Type-I diabetes: a chronic autoimmune disease of human, mouse, and rat. Annu. Rev. Immunol. 8: 647-679
2. Bach J.R 1994. Insulin-dependent diabetes mellitus as an autoimmune disease. Endocr. Rev. 15: 516-542
3. Katz J.D., Wang B., Haskins K., Benoist C., Mathis D. 1993. Following a diabetogenic T cell from genesis through pathogenesis. Cell 74: 1089-1100
4. Katz J.D., Benoist C., Mathis D. 1995. T helper cell subsets in insulin-dependent diabetes. Science 268: 1185-1188
5. Andre I., Gonzalez A., Wang B., Katz J., Benoist C., Mathis D. 1996. Checkpoints in the progression of autoimmune disease: lessons from diabetes models. Proc. Natl. Acad. Sci. USA 93: 2260-2263
6. Chervonsky A.V., Wang Y., Wong F.S., Visintin I., Flavell R.A., Janeway C.A. Jr., Matis L.A. 1997. The role of Fas in autoimmune diabetes. Cell 89: 17-24
7. Bieg S., Bailyes E.M., Yassin N., Amann J., Herberg L., McGregor A.M., Scherbaum W.A., Banga J.P. 1993. A multiplicity of protein antigens in subcellular fractions of rat insulinoma tissue are able to stimulate T cells obtained from non-obese diabetic mice. Diabetologia 36: 385-390
8. Serreze D.V., Leiter E.H. 1994. Genetic and pathogenic basis of autoimmune diabetes in NOD mice. Curr. Opin. Immunol. 6: 900-906
9. Martignat L., Elmansour A., Audrain M., Julien J.F., Charbonnel B., Sai P. 1995. Pancreatic expression of antigens for islet cell antibodies in non-obese diabetic mice. J. Autoimmun. 8: 465-482
10. Gottlieb P.A., Eisenbarth G.S. 1996. Mouse and man: multiple genes and multiple autoantigens in the aetiology of type IDM and related autoimmune disorders. J. Autoimmun. 9: 277-281
11. Bergman B., Haskins K. 1997. Autoreactive T-cell clones from the nonobese diabetic mouse. Proc. Soc. Exp. Biol. Med. 214: 41-48
12. Maclaren N.K., Alkinson M.A. 1997. Insulin-dependent diabetes mellitus: the hypothesis of molecular mimicry between islet cell antigens and microorganisms. Mol. Med. Today 3: 76-83
13. Segurado O.G., Arnaiz-Villena A., Wank R., Schendel D.J. 1993. The multifactoral nature of MHC-linked susceptibility to insulin-dependent diabetes. Autoimmunity 15: 85-89
14. Robinson B.H., Dosch H.M., Martin J.M., Akerblom H.K., Savilahti E., Knip M., Ilonen J. 1993. A model for the involvement of MHC class II proteins in the development of type 1 (insulin-dependent) diabetes mellitus in response to bovine serum albumin peptides. Diabetologia 36: 364-368
15. Hitman G.A. 1993. The immunogenetics of insulin-dependent diabetes. Eye 7: 209-213
16. McDevitt H., Singer S., Tisch R. 1996. The role of MHC class II genes in susceptibility and resistance to type I diabetes mellitus in the NOD mouse. Horm. Metab. Res. 28: 287-288
17. Todd J.A., Acha-Orbea H., Bell J.I., Chao N., Fronek Z., Jacob C.O., McDermott M., Sinha A.A., Timmerman L., Steinman L., et al. 1988. A molecular basis for MHC class II-associated autoimmunity. Science 240: 1003-1009
18. Todd J.A., Bell J.I., McDevitt H.O. 1987. HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 329: 599-604
19. Todd J.A., Bell J.I., McDevitt H.O. 1988. A molecular basis for genetic susceptibility to insulin-dependent diabetes mellitus. Trends Genet. 4: 129-134
20. Achaa-Orbea H., McDevitt H.O. 1987. The first external domain of the nonobese diabetic mouse class II I-A beta chain is unique. Proc. Natl. Acad. Sci. USA 84: 2435-2439
21. Acha-Orbea H., McDevitt H.O. 1990. The role of class II molecules in development of insulin-dependent diabetes mellitus in mice, rats and humans. Curr. Top. Microbiol. Immunol. 156: 103-119
22. Chao N.J., Timmerman L., McDevitt H.O., Jacob C.O. 1989. Molecular characterization of MHC class II antigens (beta 1 domain) in the BB diabetes-prone and -resistant rat. Immunogenetics 29: 231-234
23. Morel P.A., Dorman J.S., Todd J.A., McDevitt H.O., Trucco M. 1988. Aspartic acid at position 57 of the HLA-DQ beta chain protects against type I diabetes: a family study [published erratum appears in Proc. Natl. Acad. Sci. USA 1989 86(4): 1317]. Proc. Natl. Acad. Sci. USA 85: 8111-8115
24. Reich E.P., von Grafenstein H., Barlow A., Swenson K.E., Williams K., Janeway C.A., Jr. 1994. Self peptides isolated from MHC glycoproteins of non-obese diabetic mice. J. Immunol. 152: 2279-2288
25. Miyazaki T., Uno M., Uehira M., Kikutani H., Kishimoto T., Kimoto M., Nishimoto H., Miyazaki J., Yamamura K. 1990. Direct evidence for the contribution of the unique I-ANOD to the development of insulitis in non-obese diabetic mice. Nature 345: 722-724
26. Carrasco-Marin E., Shimizu J., Kanagawa O., Unanue E.R. 1996. The class II MHC I-Ag7 molecules from non-obese diabetic mice are poor peptide binders. J. Immunol. 156: 450-458
27. Reizis B., Eisenstein M., Bockova J., Konen-Waisman S., Mor F., Elias D., Cohen I.R. 1997. Molecular characterization of the diabetes-associated mouse MHC class II protein, I-Ag7. Int. Immunol. 9: 43-51
28. Harrison L.C., Honeyman M.C., Trembleau S., Gregori S., Gallazzi F., Augstein P., Brusic V., Hammer J., Adorini L. 1997. A peptide-binding motif for I-A(g7), the class II major histocompatibility complex (MHC) molecule of NOD and Biozzi AB/H mice. J. Exp. Med. 185: 1013-1021
29. Sadegh-Nasseri S., Germain R.N. 1991. A role for peptide in determining MHC class II structure. Nature 353: 167-170
30. Germain R.N., Hendrix L.R. 1991. MHC class II structure, occupancy and surface expression determined by post-endoplasmic reticulum antigen binding. Nature 353: 134-139
31. Stern L.J., Wiley D.C. 1992. The human class II MHC protein HLA-DR1 assembles as empty alpha beta heterodimers in the absence of antigenic peptide. Cell 68: 465-477
32. Nelson C.A., Petzold S.J., Unanue E.R. 1994. Peptides determine the lifespan of MHC class II molecules in the antigen-presenting cell. Nature 371: 250-252
33. Germain R.N., Malissen B. 1986. Analysis of the expression and function of class-II major histocompatibility complex-encoded molecules by DNA-mediated gene transfer. Annu. Rev. Immunol. 4: 281-315
34. Ronchese F., Schwartz R.H., Germain R.N. 1987. Functionally distinct subsites on a class II major histocompatibility complex molecule. Nature 329: 254-256
35. Kim K.J., Kanellopoulos-Langevin C., Merwin R.M., Sachs D.H., Asofsky R. 1979. Establishment and characterization of BALB/c lymphoma lines with B cell properties. J. Immunol. 122: 549-554
36. 67) prevents autoimmune diabetes in NOD mice. Diabetes 43: 1494-1499
37. Oi V.T., Jones P.P., Goding J.W., Herzenberg L.A., Herzenberg L.A. 1978. Properties of monoclonal antibodies to mouse Ig allotypes, H-2, and Ia antigens. Curr. Top. Microbiol. Immunol. 81: 115-120
38. Madrenas J., Chau L.A., Smith J., Bluestone J.A., Germain R.N. 1997. The efficiency of CD4 recruitment to ligand-engaged TCR controls the agonist/partial agonist properties of peptide-MHC molecule ligands. J. Exp. Med. 185: 219-229
39. Allison J.P., Krummel M.F. 1995. The yin and yang of T cell costimulation. Science 270: 932-933
40. Lenschow D.J., Walunas T.L., Bluestone J.A. 1996. CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 14: 233-258
41. Croft M., Dubey C. 1997. Accessory molecule and costimulation requirements for CD4 T cell response. Crit. Rev. Immunol. 17: 89-118
42. Zechel M.A., Chaturvedi P., Lee-Chan E.C., Rider B.J., Singh B. 1996. Modulation of antigen presentation and class II expression by a class II-associated invariant chain peptide. J. Immunol. 156: 4232-4239
43. Tompkins S.M., Moore J.C., Jensen P.E. 1996. An insulin peptide that binds an alternative site in class II major histocompatibility complex. J. Exp. Med. 183: 857-866
44. Long E.O., LaVaute T., Pinet V., Jaraquemada D. 1994. Invariant chain prevents the HLA-DR-restricted presentation of a cytosolic peptide. J. Immunol. 153: 1487-1494
45. Germain R.N. 1995. Binding domain regulation of MHC class II molecule assembly, trafficking, fate, and function. Semin. Immunol. 7: 361-372
46. Bertolino P., Rabourdin-Combe C. 1996. The MHC class II-associated invariant chain: a molecule with multiple roles in MHC class II biosynthesis and antigen presentation to CD4+ T cells. Crit. Rev. Immunol. 16: 359-379
47. Bikoff E.K., Germain R.N., Robertson E.J. 1995. Allelic differences affecting invariant chain dependency of MHC class II subunit assembly. Immunity 2: 301-310
48. Peterson M., Miller J. 1990. Invariant chain influences the immunological recognition of MHC class II molecules. Nature 345: 172-174
49. Harding C.V., Unanue E.R. 1990. Quantitation of antigen-presenting cell MHC class II/peptide complexes necessary for T-cell stimulation. Nature 346: 574-576
50. Demotz S., Grey H.M., Sette A. 1990. The minimal number of class II MHC-antigen complexes needed for T cell activation. Science 249: 1028-1030
51. Kim J., Richter W., Aanstoot H.-J., Shi Y., Fu Q., Rajotte R., Warnock G., Baekkeskov S. 1993. Differential expression of GAD-65 and GAD-67 in pancreatic islets of man, rat, and mouse. Diabetes 42: 1799-1808
52. Tisch R., Yang X.D., Singer S.M., Liblau R.S., Fugger L., McDevitt H.O. 1993. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature 366: 72-75